NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-27 22:05இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Quick Heal Q2 FY27 Consolidated Revenue at ₹64.93 Cr, Down 22.3% YoY; Appoints GT as Internal Auditor
Quick Heal Technologies reported consolidated revenue from operations of ₹64.93 Cr for the quarter ended September 30, 2026, a decline of 22.3% YoY compared to ₹83.52 Cr in Q2 FY26, though up 44.3% QoQ from ₹44.99 Cr. Total consolidated income for the quarter stood at ₹73.27 Cr compared to ₹87.90 Cr in the year-ago period. Alongside results, the Board appointed Grant Thornton Bharat LLP as Internal Auditor for FY27 and named Shailesh Shinde as Company Secretary, Compliance Officer, and Nodal Officer.
உச்சம் நம்பிக்கை
என்ன மாறியதுQuick Heal reported its Q2 FY27 financial performance and revamped internal audit and compliance leadership with the appointment of Grant Thornton Bharat LLP and a new Company Secretary.
ஏன் இது முக்கியம்The 22.3% YoY revenue contraction highlights ongoing topline pressure in the core consumer antivirus business, though QoQ recovery provides partial relief against seasonal low quarters.
Consolidated Revenue (Q2 FY27): ₹64.93 கோடிYoY Revenue De-growth: -22.3%Consolidated Total Income (Q2 FY27): ₹73.27 கோடிH1 FY27 Revenue: ₹109.92 கோடி
📅 குறுகிய காலம்The continuing YoY de-growth in Q2 revenue may weigh on market sentiment despite seasonal sequential recovery from Q1.
📈 நீண்ட காலம்Long-term recovery hinges on the operational pivot towards enterprise cybersecurity (Seqrite EDR/XDR) offsetting stagnation in retail consumer products.
⚠ அபாய எச்சரிக்கைகள்
Persistent YoY revenue decline (-22.3% YoY in Q2)
Headwinds in the consumer cybersecurity segment and retail collection delays
👀 கவனிக்க வேண்டியவை
Track subsequent quarters to see if the Enterprise segment (Seqrite) can compensate for ongoing Consumer business softness and help restore operating margins.
Quick Heal SVP - Enterprise Sales Samuel Sathyajith Steps Down Effective Sep 4, 2026
Quick Heal Technologies Limited has confirmed the cessation of Mr. Samuel Sathyajith as Senior Vice President - Enterprise Sales, effective September 4, 2026, following his resignation letter dated August 11, 2026. The departure comes at a crucial juncture as Quick Heal pivots toward its enterprise arm (Seqrite), which contributes approximately 44% of gross revenue. The company reported TTM revenue of Rs 249 Cr and a TTM net loss of Rs 11 Cr, making enterprise sales execution critical to returning to operating profitability.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. Samuel Sathyajith's tenure as Senior Vice President - Enterprise Sales concluded on September 4, 2026.
ஏன் இது முக்கியம்The Enterprise business is Quick Heal's primary growth driver amid consumer segment stagnation; leadership disruption in sales could impact deal pipelines and enterprise revenue growth.
Effective Date of Cessation: செப்டம்பர் 4, 2026Resignation Intimation Date: ஆகஸ்ட் 11, 2026Enterprise Share of Gross Revenue: 44%TTM Net Profit: Rs -11 Cr
📅 குறுகிய காலம்Sales transition risks could lead to temporary friction in enterprise and government contract conversions over the coming quarters.
📈 நீண்ட காலம்Sustainable turnaround depends heavily on Seqrite's EDR and XDR product expansion; smooth succession in enterprise sales leadership will be vital.
⚠ அபாய எச்சரிக்கைகள்
Key management departure in the high-growth Enterprise business segment
Ongoing operational losses (TTM PAT of Rs -11 Cr)
👀 கவனிக்க வேண்டியவை
Track announcements regarding the appointment of new enterprise sales leadership and monitor enterprise revenue momentum in the upcoming Q2 FY27 results.
Quick Heal SVP of Enterprise Sales Samuel Sathyajith Resigns; Exit by Sep 4, 2026
Quick Heal Technologies announced that Mr. Samuel Sathyajith, Senior Vice President - Enterprise Sales, has tendered his resignation on August 11, 2026, to pursue other professional opportunities. His last working day will be on or before September 4, 2026. This departure comes at a crucial juncture as Quick Heal pivots toward its Enterprise segment (Seqrite), which contributes approximately 44% of gross revenue. The company will announce the effective cessation date within regulatory timelines.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. Samuel Sathyajith, Senior Vice President - Enterprise Sales, resigned on August 11, 2026, with an effective exit date on or before September 4, 2026.
ஏன் இது முக்கியம்The Enterprise division (Seqrite) is Quick Heal's primary growth driver contributing ~44% of gross revenue, making leadership continuity critical during its transition away from a stagnant consumer segment.
Resignation Intimation Date: ஆகஸ்ட் 11, 2026Last Working Day: On or before September 4, 2026Enterprise share of gross revenue: ~44%
📅 குறுகிய காலம்Low operational disruption expected over the immediate weeks ahead of his transition date of September 4, 2026.
📈 நீண்ட காலம்Leadership execution risk in scaling the mid-market and SMB enterprise sales pipeline if key leadership replacement is delayed.
⚠ அபாய எச்சரிக்கைகள்
Key personnel transition risk in the core growth division (Enterprise/Seqrite)
👀 கவனிக்க வேண்டியவை
Track announcements regarding succession planning and appointment of the new Enterprise Sales head, alongside upcoming quarterly Enterprise (Seqrite) segment growth figures.
Quick Heal Appoints 30-Year IBM Veteran Rajiv Sreekantan as SVP - Enterprise Sales
Quick Heal Technologies has appointed Mr. Rajiv Sreekantan as Senior Vice President - Enterprise Sales, effective August 11, 2026. This high-profile hire from IBM (26-year tenure) is strategically aligned with the company's pivot toward its 'Seqrite' enterprise segment, which now contributes 44% of gross revenue. Given the company's TTM net loss of ₹11 Cr and declining annual revenue (₹261 Cr in FY26 vs ₹292 Cr in FY24), this leadership change is critical for scaling B2B sales and government contracts.
உச்சம் நம்பிக்கை
என்ன மாறியதுQuick Heal has replaced or added senior leadership for its most critical growth vertical, hiring a veteran from a global technology giant (IBM).
ஏன் இது முக்கியம்The company is currently loss-making and facing headwinds in its traditional consumer business; the success of the Enterprise pivot is essential for returning to profitability and justifying its ₹807 Cr market cap.
Experience of Appointee: 30+ yearsTenure at IBM: 26 yearsEnterprise Revenue Contribution: 44%TTM Net Profit: ₹-11 கோடிTTM வருவாய்: ₹261 கோடி
📅 குறுகிய காலம்The market may view this as a positive signal of the company's intent to professionalize and scale its B2B operations, potentially stabilizing the stock after a 46.7% 12-month decline.
📈 நீண்ட காலம்If the new leadership successfully leverages its experience with large-scale enterprise transformations, it could structurally shift Quick Heal from a retail-focused antivirus firm to a diversified B2B cybersecurity player.
⚠ அபாய எச்சரிக்கைகள்
Execution risk in transitioning from a global MNC environment to a mid-cap Indian firm
High cost of senior talent potentially impacting short-term margins
👀 கவனிக்க வேண்டியவை
Watch for growth in the Enterprise (Seqrite) revenue contribution and the conversion of 'big-ticket' government contracts in the next 2-4 quarters to validate the impact of this leadership change.
₹5.28 Cr Net Loss in Q1 FY27; Revenue Declines 21% YoY to ₹44.99 Cr
Quick Heal Technologies reported a consolidated net loss of ₹5.28 Cr for Q1 FY27, compared to a loss of ₹5.51 Cr in the same period last year. Revenue from operations fell significantly by 21.4% YoY to ₹44.99 Cr, representing only 17% of TTM revenue. The bottom line was heavily supported by a one-time 'Other Income' of ₹14.10 Cr, which includes a ₹6.73 Cr service tax refund. Operationally, the company remains under pressure as employee benefit expenses of ₹43.20 Cr consumed nearly 96% of its operational revenue.
உச்சம் நம்பிக்கை
என்ன மாறியதுQuick Heal reported its Q1 FY27 results showing a sharp revenue contraction and continued losses, alongside the formal start of the new CEO's tenure and a shift in registered office.
ஏன் இது முக்கியம்The results highlight ongoing challenges in the consumer cybersecurity market and a high fixed-cost structure that makes the company vulnerable during low-revenue quarters.
Revenue (Q1 FY27): ₹44.99 கோடிYoY Revenue Growth: -21.4%Net Loss (Q1 FY27): ₹5.28 கோடிOne-time Tax Refund: ₹6.73 கோடிEmployee Cost as % of Revenue: 96.02%Revenue vs TTM Revenue: 17.2%
📅 குறுகிய காலம்The stock is likely to remain under pressure due to the double-digit revenue decline and operational losses, despite the one-time tax refund narrowing the net loss.
📈 நீண்ட காலம்Structural recovery depends on the Enterprise segment (Seqrite) achieving enough scale to cover the high R&D and sales headcount costs, which are currently weighing on margins.
⚠ அபாய எச்சரிக்கைகள்
High employee cost concentration
Declining revenue trend in core operations
Reliance on one-time other income to support PAT
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the new CEO, Harish Kumar GS, specifically regarding the pivot to the Enterprise (Seqrite) segment to offset Consumer segment weakness. Watch for any reduction in the high employee-cost-to-revenue ratio in upcoming quarters.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Resignation of Chief Product Officer Dr. Lalit Mohan Sanagavarapu
Quick Heal Technologies has announced the resignation of its Chief Product Officer (CPO), Dr. Lalit Mohan Sanagavarapu, effective August 7, 2026. The resignation, cited for personal reasons, follows a discussion initiated on June 8, 2026. This leadership change occurs as the company is undergoing a critical pivot from its stagnant consumer business to the Enterprise segment (Seqrite), which now contributes 44% of gross revenue. Given the company's TTM loss of ₹11 crore and negative operating margins, the departure of a key product leader is a notable development for the execution of its R&D-heavy strategy.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Chief Product Officer, a key senior management personnel responsible for product strategy and R&D, has exited the company.
ஏன் இது முக்கியம்The CPO role is vital for Quick Heal's transition into the high-growth Enterprise cybersecurity market; leadership instability during a period of financial losses (₹11 cr TTM loss) could impact product innovation and market competitiveness.
Effective Date of Cessation: ஆகஸ்ட் 7, 2026Enterprise Revenue Contribution: 44%TTM வருவாய்: ₹261 கோடிTTM PAT: ₹-11 crOperating Profit Margin (TTM): -11.1%
📅 குறுகிய காலம்The immediate impact may be neutral to slightly negative as the market processes the loss of a key executive during a turnaround phase.
📈 நீண்ட காலம்The long-term impact depends on the company's ability to attract a replacement who can maintain the momentum of the Seqrite enterprise brand and return the company to profitability.
⚠ அபாய எச்சரிக்கைகள்
Key management personnel turnover
Execution risk in product pivot
Ongoing financial losses
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's announcement regarding a successor and check for any delays in the roadmap for new products like Sentinel Threat Intelligence (STI) and SMAP in upcoming quarterly updates.
Quick Heal Q1 FY27 Revenue Drops 21% to ₹45 Cr; Reports ₹5.3 Cr Net Loss
Quick Heal Technologies reported a weak Q1 FY27 with consolidated revenue declining 21.3% YoY to ₹45.0 cr, down from ₹57.2 cr. The company faced significant operating pressure with an EBITDA loss of ₹17.6 cr (margin of -39.1%) compared to a loss of ₹9.7 cr in the previous year. Net loss narrowed slightly to ₹5.3 cr from ₹5.5 cr YoY, primarily supported by a sharp increase in 'Other Income' to ₹14.1 cr. Despite consumer segment headwinds, the company secured a notable multi-year order for 1.5 lakh devices from the Defence sector.
உச்சம் நம்பிக்கை
என்ன மாறியதுQuick Heal reported a significant year-on-year revenue contraction and widened operating losses for Q1 FY27, while simultaneously announcing a major government order win and the re-appointment of a key independent director.
ஏன் இது முக்கியம்The results highlight the ongoing struggle in the company's core consumer business, making the pivot to Enterprise and Government segments (B2B/B2G) critical for financial recovery and long-term sustainability.
📅 குறுகிய காலம்The stock is likely to face negative sentiment in the short term due to the double-digit revenue decline and continued operating losses.
📈 நீண்ட காலம்The long-term outlook depends on the successful scaling of the Seqrite enterprise arm and high-margin government contracts to replace the shrinking consumer software base.
⚠ அபாய எச்சரிக்கைகள்
Continued revenue contraction in the consumer segment
Widening operating losses
High reliance on non-operating income to support PAT
Collection challenges from retail partners
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution timeline of the 1.5 lakh device Defence order and the pace of the 'Seqrite' enterprise segment's growth to offset consumer segment declines. Watch for stabilization in operating margins and partner credit control in upcoming quarters.
Quick Heal re-appoints cybersecurity expert Richard Stiennon for a 5-year second term
Quick Heal Technologies has proposed the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026. Stiennon is a globally recognized cybersecurity analyst with over 30 years of experience, having advised industry leaders like Symantec, McAfee, and Microsoft. This retention of high-caliber global expertise is significant as the company pivots toward its Enterprise segment (Seqrite), which now accounts for 44% of gross revenue. The move comes as the company seeks to reverse a TTM net loss of ₹11 Cr through international expansion and product diversification.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board has recommended the extension of Richard Stiennon's tenure as an Independent Director for an additional five years, subject to shareholder approval.
ஏன் இது முக்கியம்Retaining a director with deep global cybersecurity expertise is crucial for Quick Heal's strategic shift toward Enterprise solutions and its expansion into Southeast Asia and Middle Eastern markets, especially given recent financial headwinds.
Term Duration: 5 yearsEffective Date: செப்டம்பர் 27, 2026Industry Experience: 30+ yearsEnterprise Revenue Contribution: 44%TTM வருவாய்: ₹261 கோடி
📅 குறுகிய காலம்The announcement provides stability and continuity at the board level, which is likely to be viewed neutrally to slightly positively by the market in the coming weeks.
📈 நீண்ட காலம்Stiennon's continued involvement is structurally significant for the company's R&D and international strategy as it attempts to transition from a consumer-focused player to a global enterprise security provider.
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming Annual General Meeting (AGM) for shareholder approval of this re-appointment and look for updates on the Enterprise segment's growth in subsequent quarterly results.
Quick Heal Appoints Cybersecurity Veteran Harish Kumar GS as CEO
Quick Heal Technologies Limited has appointed Mr. Harish Kumar GS as its Chief Executive Officer and Key Managerial Personnel, effective June 18, 2026. Mr. Kumar brings over 30 years of leadership experience in cybersecurity, enterprise software, and technology infrastructure. He previously served as the Head of Sales – India & SAARC at Check Point Software Technologies, a major global cybersecurity firm. This strategic appointment is aimed at driving business transformation and expanding the company's market presence in the mid-market and large enterprise segments.
முக்கிய அம்சங்கள்
Appointment of Mr. Harish Kumar GS as CEO and Key Managerial Personnel effective June 18, 2026.Brings over 30 years of experience across cybersecurity, networking, and digital services.Previously served as Head of Sales – India & SAARC at Check Point Software Technologies.The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive move to strengthen leadership with a veteran from a global cybersecurity leader; monitor for potential shifts in enterprise sales strategy and market expansion.
Quick Heal FY26 Revenue Drops 6.6% to ₹261 Cr; Swings to Annual Net Loss of ₹10.9 Cr
Quick Heal Technologies reported a weak financial performance for FY26, with consolidated revenue from operations declining 6.6% YoY to ₹261.02 Cr. The company swung to a consolidated net loss of ₹10.93 Cr for the full year, compared to a profit of ₹5.04 Cr in FY25. The fourth quarter was particularly poor, with revenue falling 25.2% YoY to ₹48.73 Cr and net losses widening significantly to ₹19.94 Cr. Additionally, the company announced the appointment of Rohit Kachroo as Senior Director for IT & Digital Transformation to bolster its management team.
முக்கிய அம்சங்கள்
Consolidated FY26 revenue declined to ₹261.02 Cr from ₹279.53 Cr in the previous year.Reported a consolidated net loss of ₹10.93 Cr for FY26 versus a profit of ₹5.04 Cr in FY25.Q4 FY26 revenue saw a sharp decline of 25.2% YoY, falling to ₹48.73 Cr.Total expenses for FY26 rose to ₹304.49 Cr, with 'Other Expenses' increasing to ₹103.21 Cr.Cash and cash equivalents decreased to ₹13.14 Cr as of March 31, 2026, down from ₹20.84 Cr YoY.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company has moved from profitability to a loss-making position amid declining revenues. Monitor management's commentary regarding the turnaround strategy and the impact of new leadership on digital transformation.
Quick Heal CTO Ashish Pradhan Announces Early Retirement Effective April 30, 2026
Quick Heal Technologies Limited has announced that its Chief Technology Officer, Mr. Ashish Pradhan, retired from his position effective April 30, 2026. This move is categorized as an early retirement, following a previous extension of service granted beyond his original retirement date of August 06, 2024. As the CTO of a cybersecurity firm, his departure marks a significant transition in the company's technical leadership. The company has not yet announced a successor for the role.
முக்கிய அம்சங்கள்
Mr. Ashish Pradhan retired as Chief Technology Officer effective April 30, 2026.The executive opted for early retirement after serving an extension period.His original retirement date was previously set for August 06, 2024.The transition was filed under Regulation 30 of SEBI (LODR) Regulations, 2015.
👀 கவனிக்க வேண்டியவை
Investors should watch for the appointment of a new CTO to ensure continuity in the company's product development and cybersecurity roadmap. No immediate portfolio changes are recommended as the departure appears planned and amicable.
Quick Heal Strengthens Leadership with Four Senior Management Appointments
Quick Heal Technologies has announced a significant expansion of its senior leadership team with four key appointments and promotions effective January 29, 2026. The company has hired industry veterans including Ms. Savita Nehra (20+ years exp) as VP People and Culture and Mr. Amartya Mukherjee (25+ years exp) as VP and Head of Delivery. Additionally, Ms. Netra Deshpande (25+ years exp) has been promoted to Head of Engineering, and Mr. Nitin Bhogan (15+ years exp) joins as Director of Cyber Awareness. These appointments bring a combined experience of over 85 years from top-tier firms like Accenture, IBM, and Symantec to the company.
முக்கிய அம்சங்கள்
Ms. Savita Nehra joins as VP People and Culture with over 20 years of HR experience from Wipro and Capgemini.Mr. Amartya Mukherjee appointed as VP and Head of Delivery, bringing 25+ years of experience from Accenture and IBM.Ms. Netra Deshpande promoted to Head of Engineering with 25+ years in cybersecurity product development including Symantec.Mr. Nitin Bhogan appointed as Director Cyber Awareness with 15+ years of experience in risk consulting and Mahindra SSG.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive move to bolster execution and product delivery capabilities. Monitor if this leadership infusion leads to improved product innovation and faster market expansion in the cybersecurity segment.
Quick Heal Q3 PAT Surges to ₹6.61 Cr; YoY Profitability Improves Significantly
Quick Heal Technologies reported a significant turnaround in profitability for Q3 FY26, with net profit rising to ₹6.61 crore from just ₹0.11 crore in the same period last year. While revenue from operations saw a modest YoY increase to ₹71.54 crore, it declined sequentially from ₹83.52 crore in Q2. The company also announced a major leadership expansion with four senior management appointments and the re-classification of a promoter entity to the public category.
முக்கிய அம்சங்கள்
Net Profit (PAT) grew to ₹6.61 Cr in Q3 FY26, a massive jump from ₹0.11 Cr in Q3 FY25.Revenue from operations stood at ₹71.54 Cr, up 1.3% YoY but down 14.3% QoQ.9-month PAT for FY26 reached ₹9.01 Cr compared to ₹8.29 Cr in the previous year.Appointed four senior leaders including Savita Nehra (VP People and Culture) and Amartya Mukherjee (VP and Head of Delivery).Board approved the re-classification of Gagan Bharari Enterprises LLP from 'Promoter' to 'Public' category.
👀 கவனிக்க வேண்டியவை
The sharp YoY recovery in net profit is encouraging, though the sequential decline in revenue suggests seasonal or cyclical volatility. Investors should watch for the impact of the new leadership team on driving consistent top-line growth in the upcoming quarters.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
